(February 14, 2020, 10:22 AM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Feb. 13 said it has asked Eisai Co. Ltd. to voluntarily withdraw the company’s Belviq and Belviq XR prescription weight loss...
FDA: Withdraw Belviq Weight-Loss Drug Due To Increased Cancer In Study Subjects
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login